ArticleClinical pharmacology : advances and applications2013

A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule formulation.

Koen van Rossem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.